Figure 2. Clinical improvement and solicited events among azithromycin-treated and placebo-treated subjects at Day 5.

The desirability of outcome ranking (DOOR) incorporates elements of clinical improvement and solicited adverse events while simultaneously considering the severity of those adverse events. Presented values indicate the probability of a more desirable DOOR when assigned to placebo vs. azithromycin. Probabilities above 50% indicate a more favorable DOOR with placebo treatment. Rather than reporting probabilities of adequate clinical improvement (a study endpoint), we report its absence to align the treatment-dependent directionality show in the figure.